Search Results

There are 9111 results for: content related to: Synthesis and Quantitative Structure–Activity Relationships of Selective BCRP Inhibitors

  1. Scaffold Identification of a New Class of Potent and Selective BCRP Inhibitors

    ChemMedChem

    Volume 10, Issue 4, April 2015, Pages: 742–751, Federico Marighetti, Dr. Kerstin Steggemann, Maria Karbaum and Prof. Dr. Michael Wiese

    Version of Record online : 3 MAR 2015, DOI: 10.1002/cmdc.201402498

  2. You have full text access to this Open Access content
    Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase

    Cancer Science

    Volume 100, Issue 6, June 2009, Pages: 1118–1127, Yasuo Imai, Kyoko Ohmori, Shin’ichi Yasuda, Mariko Wada, Tsukasa Suzuki, Kazunori Fukuda and Yoshihiko Ueda

    Version of Record online : 12 MAR 2009, DOI: 10.1111/j.1349-7006.2009.01154.x

  3. You have full text access to this Open Access content
    Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene

    Cancer Science

    Volume 101, Issue 6, June 2010, Pages: 1493–1500, Haruka Kawahara, Kohji Noguchi, Kazuhiro Katayama, Junko Mitsuhashi and Yoshikazu Sugimoto

    Version of Record online : 22 FEB 2010, DOI: 10.1111/j.1349-7006.2010.01539.x

  4. You have free access to this content
    Transcriptional suppression of breast cancer resistance protein (BCRP) by wild-type p53 through the NF-κB pathway in MCF-7 cells

    FEBS Letters

    Volume 584, Issue 15, August 04, 2010, Pages: 3392–3397, Xuedong Wang, Xingang Wu, Chengkun Wang, Weijia Zhang, Yongmei Ouyang, Yanhui Yu and Zhimin He

    Version of Record online : 29 JUN 2010, DOI: 10.1016/j.febslet.2010.06.033

  5. You have free access to this content
    Quantitative Analysis of the ABCG2 c.421C>A Polymorphism Effect on In Vivo Transport Activity of Breast Cancer Resistance Protein (BCRP) Using an Intestinal Absorption Model

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 3039–3048, Yuta Tanaka, Yoshiaki Kitamura, Kazuya Maeda and Yuichi Sugiyama

    Version of Record online : 30 JAN 2015, DOI: 10.1002/jps.24366

  6. You have free access to this content
    Flow cytometric analysis of breast cancer resistance protein expression and function

    Cytometry

    Volume 48, Issue 2, 1 June 2002, Pages: 59–65, Hans Minderman, Attaya Suvannasankha, Kieran L. O'Loughlin, George L. Scheffer, Rik J. Scheper, Robert W. Robey and Maria R. Baer

    Version of Record online : 20 MAY 2002, DOI: 10.1002/cyto.10111

  7. You have free access to this content
    Induction of P-glycoprotein and Bcrp at the rat blood–brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation

    Journal of Neurochemistry

    Volume 123, Issue 4, November 2012, Pages: 491–503, Salah Yousif, Catarina Chaves, Sophie Potin, Isabelle Margaill, Jean-Michel Scherrmann and Xavier Declèves

    Version of Record online : 3 SEP 2012, DOI: 10.1111/j.1471-4159.2012.07890.x

  8. In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 2, February 2015, Pages: 170–177, Yang Lu, Takeo Nakanishi, Atsushi Hosomi, Hisakazu Komori and Ikumi Tamai

    Version of Record online : 17 DEC 2014, DOI: 10.1111/jphp.12328

  9. You have free access to this content
    Interaction of innovative small molecule drugs used for cancer therapy with drug transporters

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 345–362, K Mandery, H Glaeser and MF Fromm

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01618.x

  10. You have full text access to this Open Access content
    Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib

    Cancer Science

    Volume 100, Issue 9, September 2009, Pages: 1701–1707, Kohji Noguchi, Haruka Kawahara, Airi Kaji, Kazuhiro Katayama, Junko Mitsuhashi and Yoshikazu Sugimoto

    Version of Record online : 12 MAY 2009, DOI: 10.1111/j.1349-7006.2009.01213.x

  11. You have free access to this content
    Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells

    International Journal of Cancer

    Volume 137, Issue 7, 1 October 2015, Pages: 1610–1620, Ji Na Kong, Qian He, Guanghu Wang, Somsankar Dasgupta, Michael B. Dinkins, Gu Zhu, Austin Kim, Stefka Spassieva and Erhard Bieberich

    Version of Record online : 27 APR 2015, DOI: 10.1002/ijc.29542

  12. Obatoclax as a perpetrator in drug–drug interactions and its efficacy in multidrug resistance cell lines

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 11, November 2015, Pages: 1575–1584, Dirk Theile, David Allendorf, Bruno Christian Köhler, Adam Jassowicz and Johanna Weiss

    Version of Record online : 10 AUG 2015, DOI: 10.1111/jphp.12455

  13. You have free access to this content
    Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1

    British Journal of Pharmacology

    Volume 158, Issue 8, December 2009, Pages: 1942–1950, A Dreiseitel, B Oosterhuis, KV Vukman, P Schreier, A Oehme, S Locher, G Hajak and PG Sand

    Version of Record online : 17 NOV 2009, DOI: 10.1111/j.1476-5381.2009.00495.x

  14. Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 5, November 2012, Pages: 584–598, R Elsby, C Hilgendorf and K Fenner

    Version of Record online : 10 OCT 2012, DOI: 10.1038/clpt.2012.163

  15. Inhibition of Human MDR1 and BCRP Transporter ATPase Activity by Organochlorine and Pyrethroid Insecticides

    Journal of Biochemical and Molecular Toxicology

    Volume 27, Issue 2, February 2013, Pages: 157–164, Kristin M. Bircsak, Jason R. Richardson and Lauren M. Aleksunes

    Version of Record online : 20 NOV 2012, DOI: 10.1002/jbt.21458

  16. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  17. You have free access to this content
    Ingredients in Fruit Juices Interact with Dasatinib Through Inhibition of BCRP: A New Mechanism of Beverage–Drug Interaction

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 1, January 2015, Pages: 266–275, Brett Fleisher, Jesse Unum, Jie Shao and Guohua An

    Version of Record online : 21 NOV 2014, DOI: 10.1002/jps.24289

  18. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 8, August 2012, Pages: 1074–1083, Min-Koo Choi and Im-Sook Song

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.2042-7158.2012.01498.x

  19. Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway

    ChemMedChem

    Volume 7, Issue 4, April 2012, Pages: 650–662, Dr. Anne Pick and Prof. Dr. Michael Wiese

    Version of Record online : 22 FEB 2012, DOI: 10.1002/cmdc.201100543

  20. You have free access to this content
    Drug transporters in the human blood-placental barrier

    British Journal of Pharmacology

    Volume 158, Issue 3, October 2009, Pages: 665–678, Kirsi Vähäkangas and Päivi Myllynen

    Version of Record online : 25 SEP 2009, DOI: 10.1111/j.1476-5381.2009.00336.x